Recombinant multiepitope proteins expressed in Escherichia coli cells and their potential for immunodiagnosis
Authors:
Open Access
- 22 May 2024
- journal article
- review article
- Published by Springer Nature in Microbial Cell Factories
- Vol. 23 (1) , 1-32
Abstract
Recombinant multiepitope proteins (RMPs) are a promising alternative for application in diagnostic tests and, given their wide application in the most diverse diseases, this review article aims to survey the use of these antigens for diagnosis, as well as discuss the main points surrounding these antigens. RMPs usually consisting of linear, immunodominant, and phylogenetically conserved epitopes, has been applied in the experimental diagnosis of various human and animal diseases, such as leishmaniasis, brucellosis, cysticercosis, Chagas disease, hepatitis, leptospirosis, leprosy, filariasis, schistosomiasis, dengue, and COVID-19. The synthetic genes for these epitopes are joined to code a single RMP, either with spacers or fused, with different biochemical properties. The epitopes’ high density within the RMPs contributes to a high degree of sensitivity and specificity. The RMPs can also sidestep the need for multiple peptide synthesis or multiple recombinant proteins, reducing costs and enhancing the standardization conditions for immunoassays. Methods such as bioinformatics and circular dichroism have been widely applied in the development of new RMPs, helping to guide their construction and better understand their structure. Several RMPs have been expressed, mainly using theEscherichia coliexpression system, highlighting the importance of these cells in the biotechnological field. In fact, technological advances in this area, offering a wide range of different strains to be used, make these cells the most widely used expression platform. RMPs have been experimentally used to diagnose a broad range of illnesses in the laboratory, suggesting they could also be useful for accurate diagnoses commercially. On this point, the RMP method offers a tempting substitute for the production of promising antigens used to assemble commercial diagnostic kits.Keywords
This publication has 231 references indexed in Scilit:
- Exploiting Folding and Degradation Machineries To Target Undruggable Proteins: What Can a Computational Approach Tell Us?ChemMedChem, 2021
- Quantification of proteomic and metabolic burdens predicts growth retardation and overflow metabolism in recombinant Escherichia coliBiotechnology and Bioengineering, 2019
- Prediction of recombinant protein production by Escherichia coli derived online from indicators of metabolic burdenBiotechnology Progress, 2018
- Evaluation of a recombinant multiepitope antigen for diagnosis of hepatitis C virus: A lower cost alternative for antigen productionJournal of Clinical Laboratory Analysis, 2018
- ESPRESSO: A system for estimating protein expression and solubility in protein expression systemsProteomics, 2013
- Fed‐batch cultivation of Escherichia coli expressed designer hepatitis C virus diagnostic intermediate and its evaluationBiotechnology and Applied Biochemistry, 2012
- Comprehensive Chiroptical Spectroscopy2012
- Evaluation of a novel fusion protein antigen for rapid serodiagnosis of tuberculosisJournal of Clinical Laboratory Analysis, 2011
- PhosphoSite: A bioinformatics resource dedicated to physiological protein phosphorylationProteomics, 2004
- Coupling of rRNA Transcription and Ribosomal Assembly in VivoJournal of Molecular Biology, 1993